Dr. Reddy's Laboratories Limited
RDY
$13.67
$0.000.00%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.01% | -16.28% | -2.25% | 34.87% | 9.10% |
| Total Depreciation and Amortization | 23.35% | 3.55% | 5.14% | 15.25% | 13.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -163.34% | 117.26% | 110.26% | -852.45% | -133.44% |
| Change in Net Operating Assets | 19.80% | -394.49% | -58.33% | -141.62% | -350.75% |
| Cash from Operations | 37.72% | -48.70% | -25.62% | -42.06% | -79.91% |
| Capital Expenditure | -84.86% | -101.91% | -38.30% | -101.03% | -29.40% |
| Sale of Property, Plant, and Equipment | -79.12% | -55.50% | 936.53% | 101.80% | 6,363.04% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 112.46% | 3,111.61% | -227.25% | 53.87% | 45.95% |
| Cash from Investing | 66.76% | -316.74% | -142.12% | 28.77% | 39.55% |
| Total Debt Issued | -64.30% | -- | 178.05% | -- | -- |
| Total Debt Repaid | -143.90% | 25.89% | 93.74% | 93.56% | -36.29% |
| Issuance of Common Stock | 177.78% | -79.88% | -75.95% | -85.97% | -88.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 1.09% | -- | -- | -- |
| Other Financing Activities | -76.38% | 1,356.47% | -31.91% | -73.01% | 8.45% |
| Cash from Financing | -88.99% | 326.56% | 736.62% | 87.72% | 793.95% |
| Foreign Exchange rate Adjustments | -103.06% | 65.60% | 118.81% | 26.88% | 159.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.69% | -0.28% | -249.12% | 11.74% | -108.90% |